These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10568160)

  • 61. The effect of plasma caeruloplasmin levels on the sensitivity for activated protein C.
    de Visser MC; Souverijn JH; Rosendaal FR; Bertina RM
    Br J Haematol; 2002 Sep; 118(3):843-6. PubMed ID: 12181057
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [P-pills, hormonal substitution and surgery--yes, or no?].
    Maltau JM; Oian P
    Tidsskr Nor Laegeforen; 1995 Mar; 115(8):934. PubMed ID: 7709380
    [No Abstract]   [Full Text] [Related]  

  • 63. The phenomenon known as acquired activated protein C resistance.
    Clark P; Walker ID
    Br J Haematol; 2001 Dec; 115(4):767-73. PubMed ID: 11843807
    [No Abstract]   [Full Text] [Related]  

  • 64. Acquired activated protein C resistance in myeloma patients with venous thromboembolic events.
    Deitcher SR; Choueiri T; Srkalovic G; Hussein MA
    Br J Haematol; 2003 Dec; 123(5):959. PubMed ID: 14632794
    [No Abstract]   [Full Text] [Related]  

  • 65. Hormones and cardiovascular diseases: oral contraceptives and hormonal replacement therapy: differential effects on coronary heart disease, deep venous thrombosis and stroke. The ESHRE Capri Workshop Group.
    Hum Reprod; 1998 Aug; 13(8):2325-33. PubMed ID: 9756321
    [No Abstract]   [Full Text] [Related]  

  • 66. [The ABO erythrocytic antigenic system as a possible predisposing factor for the appearance of venous thrombotic pathology].
    Iturbe Hernández T; Moreno Chulilla JA; de Miguel Olmeda R; Cornudella Lacasa R
    Rev Clin Esp; 2000 Jan; 200(1):49-50. PubMed ID: 10721296
    [No Abstract]   [Full Text] [Related]  

  • 67. [Use the entire "analysis package" when investigating patients with venous thrombosis! Don't forget the relatives...].
    Persson KE; Hillarp A; Lethagen S; Berntorp E; Dahlbäck B
    Lakartidningen; 2000 Nov; 97(47):5452-6. PubMed ID: 11192769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carbohydrate structure in factor VIII.
    Austen DE; Bidwell E
    Thromb Diath Haemorrh; 1972 Dec; 28(3):464-72. PubMed ID: 4675267
    [No Abstract]   [Full Text] [Related]  

  • 69. More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 2000 Aug; 20(4):397-8. PubMed ID: 10917398
    [No Abstract]   [Full Text] [Related]  

  • 70. ABO blood group and ischaemic heart disease.
    Boulton FE
    BMJ; 1990 Aug; 301(6746):290. PubMed ID: 2117974
    [No Abstract]   [Full Text] [Related]  

  • 71. Results of an electronic mail survey on hormones and telangiectasias.
    Ricci S
    Dermatol Surg; 2005 Feb; 31(2):246-8. PubMed ID: 15762225
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Factor VIII concentrates. Problems and protein chemistry characterization].
    Kröniger A; Kumpe A; Wormsbächer W; Herchenhahn B
    Med Welt; 1982 Jul; 33(28):1027-33. PubMed ID: 6811831
    [No Abstract]   [Full Text] [Related]  

  • 73. Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases.
    Olsson E; Höijer P
    Br J Plast Surg; 2005 Jul; 58(5):720-3. PubMed ID: 15992531
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes of hemostatic variables during oral contraceptive use.
    Tans G; Bouma BN; Büller HR; Rosing J
    Semin Vasc Med; 2003 Feb; 3(1):61-8. PubMed ID: 15199493
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Activated protein C resistance of an acquired nature: the potential role of hormonal treatment and of elevated factor VIII plasma levels].
    Iturbe Hernández T; Varo MJ; Olave MT; Fuertes MA; Cornudella R
    Rev Clin Esp; 1999 Sep; 199(9):618. PubMed ID: 10568160
    [No Abstract]   [Full Text] [Related]  

  • 76. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.
    Raps M; Curvers J; Helmerhorst FM; Ballieux BE; Rosing J; Thomassen S; Rosendaal FR; van Vliet HA
    Thromb Res; 2014 Apr; 133(4):640-4. PubMed ID: 24438944
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.